MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,089 | +20.6% | 25,000 | 0.0% | 0.05% | -67.3% |
| Q2 2023 | $903 | -2.9% | 25,000 | 0.0% | 0.16% | +58.8% |
| Q1 2023 | $930 | -17.9% | 25,000 | 0.0% | 0.10% | -59.2% |
| Q4 2022 | $1,133 | -99.9% | 25,000 | 0.0% | 0.25% | -18.3% |
| Q3 2022 | $1,746,000 | -48.0% | 25,000 | -50.0% | 0.31% | +203.0% |
| Q2 2022 | $3,356,000 | +63.2% | 50,000 | +100.0% | 0.10% | -57.0% |
| Q1 2022 | $2,056,000 | -43.9% | 25,000 | 0.0% | 0.24% | -2.5% |
| Q4 2021 | $3,667,000 | -17.1% | 25,000 | 0.0% | 0.24% | -12.0% |
| Q3 2021 | $4,423,000 | – | 25,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |